Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Aandelen, abnormal, Aktiengesellschaft, Annex, ARB, attempt, belief, Biomedical, Biosafety, BioSprint, bioterrorism, Bloodbourne, Boerse, bond, broader, broadest, Chester, Circle, Clarification, clearance, composed, concede, Connecticut, consecutive, contingency, contingent, coupon, Creation, crime, criterion, cRNA, curtail, deceased, default, depletion, DHL, diligence, Displacement, distributor, downturn, expenditure, FIN, Fisher, forward, Foundation, fractionation, fragmentation, GMO, great, Haven, Hazard, idle, Indenture, interrupted, intrinsic, inventor, IvDD, Karobathstudied, MDA, MDxDSP, membership, milestone, MSI, multiplied, multiplying, NYSE, OBI, OSHA, overcoming, Oversight, paragraph, partly, phone, Preferente, proteomic, QGEN, Qproteome, RCAT, realign, realigned, realignment, reappointed, reassessment, refinance, refocused, regime, reliance, repaid, repay, repurchase, rest, retail, revaluation, Rolling, scarce, Schatzjoined, smallest, SPAQ, spoilage, stand, sustain, threat, TMO, travel, Trustee, unanimity, unsubordinated, violation, vulnerable, warrant, WGA
Removed:
activated, actively, adsorb, affiliated, Alameda, alliance, ambion, America, analyzed, answer, antidilutive, applicability, arm, arrayable, assay, assignment, auditing, automatable, automate, bacterial, BD, begin, bind, biopharmaceutical, blend, blueprint, Boom, borrow, Borse, break, breakthrough, broken, buffer, bulk, bundle, bundled, capability, capable, capitalization, capture, CARDION, carryforward, carryover, cationic, ceased, cellular, cellulose, cerevisiae, Chain, chelate, chelating, CHF, choose, chosen, chromatography, circular, clearing, Cleavable, cleaving, clinically, cm, coated, coli, collected, collecting, column, combated, combine, combined, combining, commenced, commercialize, comparison, comprise, consortium, consultative, consuming, contact, contaminating, convenient, convey, copied, covering, CpG, CRM, crude, culture, cultured, cured, cycler, degradation, degraded, dendrimer, design, destroy, detergent, directional, discussion, disrupt, disseminating, diversify, donated, drawn, DSM, dynamic, easier, easily, economical, edge, edition, effectene, Ehrlich, elution, emphasize, employing, Empore, encoded, encompassing, endofree, endotoxin, enhanced, enhancement, enhancing, enzymatic, EPICEPT, eventually, exchanged, excluding, exponentially, extension, extremely, falciparum, faster, fastest, feedback, filtered, filtration, Fine, flexible, fluorescence, format, formation, formulated, formulation, fragile, frequently, fueled, GeneMedicine, govern, Green, harbor, hardware, harvested, Haserjian, HCV, HiSpeed, Histidine, historic, hormone, HotStarTaq, HS, hundred, hybrid, hybridization, ideal, immunization, immunoassay, improvement, inclusion, Indemnity, induce, induced, induction, inexpensive, influenza, initiated, initiative, insect, insertion, insoluble, insulin, intact, integrity, interaction, interferon, involving, Iowa, isolate, isolated, Jersey, labeling, larger, LCx, leveraged, LIBOR, ligand, linear, link, lipid, living, longmer, lysate, maintaining, mammalian, man, marginal, Masscode, massive, mechanically, melanogaster, membrane, metal, microinjection, miniprep, modifying, moving, mRNA, mutation, Mycobacterium, NTA, nucleotide, OEM, oligonucleotide, Oligotex, Omniscript, OneStep, open, optimization, optimize, optimized, Orchid, Organon, overhead, Overview, Pall, pAlliance, patented, Paul, penetrate, PerkinElmer, pertaining, phase, piece, plasma, Plasmodium, platform, PolyFect, polymerase, pooling, poor, popular, powerful, prepare, prerequisite, preservation, prevention, priced, primer, probe, procedure, productivity, profiling, prominently, promote, promoting, protected, protective, pure, purifying, QIAEX, QIAfilter, QIAprecipitator, QIAprep, QIAquick, QIAwell, quantification, RADIOMETER, RapidPlate, Rapigene, rat, realization, Realty, recombination, recommendation, recovering, recurring, Reform, regulating, removal, renamed, reproducibility, reproduction, reputation, resin, resonance, restricted, reversed, revolutionary, Richard, RLS, RNAlater, robotic, room, routine, RT, safe, safely, scattering, screening, selectively, SensiChip, Sensiscript, Sequenom, serum, shift, Sigma, signal, situated, sizeable, skill, smaller, SNP, soluble, Spectrometry, spread, stabilize, stabilizing, Stolberg, stored, structural, studied, Sugarman, suitable, SuperFect, surface, SYBR, synergistic, synergy, tag, tagged, tagging, tailored, targeted, technique, Teknika, temperature, template, terminated, thousand, tightly, tip, today, Tokyo, toxic, toxicology, trace, tracking, transcribed, transcribing, transcriptase, transfecting, TransMessenger, transported, TruPrepTM, TurboFilter, UA, ultrapurity, understand, understanding, uniquely, unparalleled, unstable, unsurpassed, vaccine, vacuum, validation, varying, vector, VGI, Visible, warehouse, washed, washing, Wave, workstation, yeast
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.1 Credit Contract for a Club Deal Between Qiagen & Deutsche Bank
- 2.2 Declaration by Qiagen N.V. to Deutsche Bank
- 2.3 Indenture Between Qiagen Finance S.a., Qiagen N.V. and Deutsche Bank
- 2.4 Agreement In Connection with the Delivery of Ordinary Shares
- 4.14 Letter Between Qiagen and DR. Joachim Schorr, Dated March 24, 2003
- 4.15 Letter Between Qiagen and DR. Joachim Schorr, Dated October 9, 2003
- 4.17 Letter Between Qiagen and Bernd Uder, Dated October 9,2003
- 4.18 Letter Between Qiagen and Bernd Uder Clarification, Dated October 9, 2003
- 4.19 Employment Agreement by and Between Qiagen and Roland Sackers, Dated 01/01/04
- 4.20 Employment Agreement by and Between Qiagen and Roland Sackers, Dated 01/05/04
- 4.21 Change of Control Agreement Between Qiagen and Roland Sackers, As of 09/30/03
- 4.22 Empolyment Agreement by and Between Qiagen N.V.& Roland Sackers, Dated 08/05/04
- 4.23 Consultancy Agreement Between Qiagen and DR. Metin Colpan, Dated 12/04/03
- 4.24 Letter Between Qiagen and Peer Schatz, Dated 10/09/03
- 8.1 List of Subsidiaries
- 12.1 Certifications Under Section 302; Peer Schatz, CEO
- 12.2 Certifications Under 302; Roland Sackers, CFO
- 13.1 Certifications Under Section 906; Peer Schatz, CEO and Roland Sackers, CFO
- 15.1 Consent of Ernst & Young LLP
QGEN similar filings
Filing view
External links
Exhibit 4.15
Dear Dr. Schorr,
In addition to your employment contract with our Company dated July 1, 1992, and the addendum to your employment contract dated June 22, 1999, we hereby clarify:
1. | The term “Company” in the “Change of Control” definition of your employment contract refers to QIAGEN N.V. |
QIAGEN GmbH
Managing Director
I agree with the above provision:
/s/ Dr. Joachim Schorr | , | dated October 9, 2003 | ||
Dr. Joachim Schorr | ||||
Employee |